Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition.
Two patients, one of whom was pregnant, developed superior vena caval thrombosis while receiving central parenteral nutrition. They were successfully treated with recombinant tissue plasminogen activator (t-PA).
Barclay
G R
GR
Department of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Allen
K
K
Pennington
C R
CR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy / Q000209:etiology*; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014683:Vena Cava, Superior
D010959:Tissue Plasminogen Activator